2.26.2010
On Friday, February 26, 2010, Mintz Levin will serve as a premier sponsor for "The Commercial Implications of Personalized Medicine" for the Tech Council of Maryland's BioBreakfast Series. Karen S. Lovitch, a member in the Health Law practice, will be moderating the panel, which will discuss such topics as commercial breakthroughs, as well as the regulatory and legislative developments expected to affect the advancement of personalized medicine in the near-term.
Your privacy is important to us. Mintz Levin uses the names, e-mail addresses, and notes you provide only to transmit the information you would like to send to us through this page. We do not sell the information collected through this website to anyone. If you are not a current Mintz Levin client, please do not include any information that you or another party considers confidential on this form. Please also see our Disclaimer & Privacy Statement.